J. THORNTON to Cost-Benefit Analysis
This is a "connection" page, showing publications J. THORNTON has written about Cost-Benefit Analysis.
Connection Strength
0.181
-
Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749.
Score: 0.133
-
Capivasertib cost-effectiveness in treating advanced breast cancer: A US health care perspective. J Manag Care Spec Pharm. 2025 Sep; 31(9):900-908.
Score: 0.048